Advanced search
Publication Cover
The World Journal of Biological Psychiatry Volume 20, 2019 - Issue 2
Submit an article Journal homepage
3,686
Views
26
CrossRef citations to date
0
Altmetric
Review Article

Is there a role for cannabidiol in psychiatry?

Julia Machado KhouryDepartment of Mental Health, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ;Postgraduation Program in Molecular Medicine, School of Medicine, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ORCID Iconhttp://orcid.org/0000-0001-8842-4972View further author information
ORCID Icon,
Maila de Castro Lourenço das NevesDepartment of Mental Health, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ORCID Iconhttp://orcid.org/0000-0003-4125-3736View further author information
ORCID Icon,
Marco Antônio Valente RoqueDepartment of Mental Health, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ORCID Iconhttp://orcid.org/0000-0003-2282-5647View further author information
ORCID Icon,
Daniela Alves de Brito QueirozDepartment of Mental Health, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ORCID Iconhttp://orcid.org/0000-0003-3671-397XView further author information
ORCID Icon,
André Augusto Corrêa de FreitasDepartment of Mental Health, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ORCID Iconhttp://orcid.org/0000-0001-9907-3645View further author information
ORCID Icon,
Ângelo de FátimaDepartment of Chemistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ORCID Iconhttp://orcid.org/0000-0003-2344-5590View further author information
ORCID Icon,
Fabrício A. MoreiraDepartment of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ORCID Iconhttp://orcid.org/0000-0002-0824-7302View further author information
ORCID Icon &
Frederico Duarte GarciaDepartment of Mental Health, Federal University of Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ;Postgraduation Program in Molecular Medicine, School of Medicine, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ;INCT de Medicina Molecular, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; ;Unité Inserm U1073, Rouen, FranceCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-1926-9053View further author information
ORCID Icon show all
Pages 101-116 | Received 05 Sep 2016, Accepted 16 Jan 2017, Published online: 20 Feb 2017

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Maurizio Popoli. (2020) Editorial. The World Journal of Biological Psychiatry 21:8, pages 577-578.
Read now
Gabriella Gobbi. (2019) A role for cannabidiol in psychiatry? Keep calm and follow the drug development rules. The World Journal of Biological Psychiatry 20:2, pages 98-100.
Read now

Articles from other publishers (24)

Toni C. Spinella, Jeremy Bartholomeusz, Sherry H. Stewart & Sean P. Barrett. (2023) Perceptions about THC and CBD effects among adults with and without prior cannabis experience. Addictive Behaviors 137, pages 107508.
Crossref
Eyal Dinur, Hagar GoldenbergElad RobinsonLior NagganEwa KozelaRaz Yirmiya. (2022) A Novel Anti-Inflammatory Formulation Comprising Celecoxib and Cannabidiol Exerts Antidepressant and Anxiolytic Effects. Cannabis and Cannabinoid Research.
Crossref
Jag H. Khalsa, Gregory Bunt, Kenneth Blum, Sanjay B. Maggirwar, Marc Galanter & Marc N. Potenza. (2022) Review: Cannabinoids as Medicinals. Current Addiction Reports 9:4, pages 630-646.
Crossref
Victoria Paulus, Joël Billieux, Amine Benyamina & Laurent Karila. (2022) Cannabidiol in the context of substance use disorder treatment: A systematic review. Addictive Behaviors 132, pages 107360.
Crossref
Zsolt Gáll, Krisztina Kelemen, Andrea Tolokán, István Zolcseak, István Sável, Réka Bod, Elek Ferencz, Szende Vancea, Melinda Urkon & Melinda Kolcsár. (2022) Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy. Biomedicines 10:8, pages 1811.
Crossref
Andrzej Silczuk, Daria Smułek, Marcin Kołodziej & Julia Gujska. (2022) The Construct of Medical and Non-Medical Marijuana—Critical Review. International Journal of Environmental Research and Public Health 19:5, pages 2769.
Crossref
Z. Gáll, A. Tolokán, I. Zolcseák, M. Urkon & M. Kolcsár. (2021) P.0244 Cannabidiol increased the seizure latency and reduced the mortality rate in the pentylenetetrazole-kindling model of epilepsy in rats. European Neuropsychopharmacology 53, pages S177.
Crossref
Anees Bahji, Marlon Danilewitz, Gustavo Vazquez & Scott Patten. (2021) The Prevalence of Cannabis Use Disorder Comorbidity in Individuals With Bipolar Disorder: A Systematic Review and Meta-Analysis. Canadian Journal of Addiction 12:3, pages 22-38.
Crossref
Kyle A. McKee, Amira Hmidan, Candice E. Crocker, Raymond W. Lam, Jeffrey H. Meyer, David Crockford, Annie Trépanier, Katherine J. Aitchison & Philip G. Tibbo. (2021) Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials. Journal of Psychiatric Research 140, pages 267-281.
Crossref
Premalatha Balachandran, Mahmoud Elsohly & Kevin P. Hill. (2021) Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review. Journal of General Internal Medicine 36:7, pages 2074-2084.
Crossref
Catherine Langlois, Stéphane Potvin, Atul Khullar & Smadar Valérie Tourjman. (2021) Down and High: Reflections Regarding Depression and Cannabis. Frontiers in Psychiatry 12.
Crossref
Amanda Timler, Caroline Bulsara, Max Bulsara, Alistair Vickery, Jill Smith & Jim Codde. (2020) Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial. Trials 21:1.
Crossref
Juliette Giacobbe, Alessia Marrocu, Maria Grazia Di Benedetto, Carmine M. Pariante & Alessandra Borsini. (2020) A systematic, integrative review of the effects of the endocannabinoid system on inflammation and neurogenesis in animal models of affective disorders. Brain, Behavior, and Immunity.
Crossref
Madison WrightPatricia Di CianoBruna Brands. (2020) Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence. Cannabis and Cannabinoid Research 5:3, pages 191-196.
Crossref
Elizabeth M. Williamson, Xinmin Liu & Angelo A. Izzo. (2020) Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals. British Journal of Pharmacology 177:6, pages 1227-1240.
Crossref
Verity L. Chadwick, Cathrin Rohleder, Dagmar Koethe & F. Markus Leweke. (2020) Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. Current Opinion in Psychiatry 33:1, pages 20-42.
Crossref
Abigail M. Freeman, Katherine Petrilli, Rachel Lees, Chandni Hindocha, Claire Mokrysz, H. Valerie Curran, Rob Saunders & Tom P. Freeman. (2019) How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review. Neuroscience & Biobehavioral Reviews 107, pages 696-712.
Crossref
Mathura T. Thiyagarajah, Nathan Herrmann, Myuri Ruthirakuhan, Abby Li & Krista L. Lanctôt. (2019) Novel Pharmacologic Strategies for Treating Behavioral Disturbances in Alzheimer’s Disease. Current Behavioral Neuroscience Reports 6:3, pages 72-87.
Crossref
Frank Y. Chou, Heather L. Armstrong, Lu Wang, Nicanor Bacani, Nathan J. Lachowsky, Thomas L. Patterson, Zach Walsh, Gbolahan Olarewaju, Kiffer G. Card, Eric A. Roth, Robert S. Hogg & David M. Moore. (2019) A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, Canada. Journal of Affective Disorders 247, pages 125-133.
Crossref
Valentin Rădoi & Gabriel Cicu. (2019) Cannabidiol – decades of research and current clinical uses. Psihiatru.ro 4:59, pages 10.
Crossref
XiaoCan Jia, YongLi Yang, YuanCheng Chen, ZhiWei Cheng, Yuhui Du, Zhenhua Xia, Weiping Zhang, Chao Xu, Qiang Zhang, Xin Xia, HongWen Deng & XueZhong Shi. (2019) Multivariate analysis of genome-wide data to identify potential pleiotropic genes for five major psychiatric disorders using MetaCCA. Journal of Affective Disorders 242, pages 234-243.
Crossref
Arjen Neven. (2017) Cannabis bij psychotische stoornissenCannabis in psychotic disorders. Verslaving 13:3, pages 165-173.
Crossref
Rami Guinguis, María Isabel Ruiz & Gabriel Rada. (2017) Is cannabidiol an effective treatment for schizophrenia?. Medwave 17:07, pages e7010-e7010.
Crossref
Ewa Kozela, Ana Juknat & Zvi Vogel. (2017) Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid. International Journal of Molecular Sciences 18:8, pages 1669.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.